dynavax  about us search homeabout usour visionmanagement teamboard of directorsdynavax europecontactour sciencetolllike receptorstlr agoniststlr inhibitorspublicationsour pipelineadjuvantshbsagcancer immunotherapysddvpreclinicalimmunemediated diseasesazd asthmainvestors and mediaoverviewpress releasesevents  presentationsstock informationanalyst coveragefinancialssec filingsannuals and proxiescorporate governanceboard of directorscommittee compositioncontact the boardcontact uscareersus job opportunitieseu job opportunitiesbenefits contact us search homeabout us›our vision›management team›board of directors›dynavax europeour science›tolllike receptors›publicationsour pipeline›adjuvants›cancer immunotherapy›immunemediated diseasesinvestors and media›overview›press releases›events  presentations›stock information›analyst coverage›financials›sec filings›annuals and proxies›corporate governance›contact uscareers›us job opportunities›eu job opportunities›benefits we are committed to utilizing the immune system to prevent and fight disease dynavax technologies corporation nasdaq dvax is a clinicalstage biopharmaceutical company with multiple product candidates in development for the prevention of infectious disease the treatment of autoimmune and inflammatory diseases and the treatment of cancer we develop immunotherapies based on cuttingedge tolllike receptor tlr biology and its ability to modulate the immune system hbsag heplisavb™  hepatitis b vaccine hbsag is an adult hepatitis b vaccine in phase  development that utilizes a proprietary tlr agonist to elicit a focused immune response designed to provide protection against hepatitis b we have submitted the biologics license application to the us food and drug administration fda the fda has established december th  as the prescription drug user fee action date sd  cancer immunotherapy we are utilizing our expertise in tlr biology to develop treatments for cancer by focusing the power of the body’s immune response on cancer cells through optimal stimulation of tlr signaling our lead cancer immunotherapy compound sd is a tlr agonist designed specifically for cancer and capable of maximal type  ifn induction and efficient maturation of plasmacytoid dendritic cells pdc to antigenpresenting cells our approach provides multiple mechanisms for attacking the tumors along with developing immune memory associated with antigens found in the tumor immunemediated diseases tlr signaling plays an important role in a variety of immunemediated diseases including asthma and certain autoimmune and inflammatory diseases through modulation of tlr signaling we are developing compounds to inhibit stimulation of tlrs that lead to autoimmune and inflammatory diseases as well using tlr agonist to rebalance the th versus th response in asthma ›our vision›management team›board of directors›dynavax europe›contact contact us    terms  conditions  dynavax technologies corporation all rights reserved dynavax  management team search homeabout usour visionmanagement teamboard of directorsdynavax europecontactour sciencetolllike receptorstlr agoniststlr inhibitorspublicationsour pipelineadjuvantshbsagcancer immunotherapysddvpreclinicalimmunemediated diseasesazd asthmainvestors and mediaoverviewpress releasesevents  presentationsstock informationanalyst coveragefinancialssec filingsannuals and proxiescorporate governanceboard of directorscommittee compositioncontact the boardcontact uscareersus job opportunitieseu job opportunitiesbenefits contact us search homeabout us›our vision›management team›board of directors›dynavax europeour science›tolllike receptors›publicationsour pipeline›adjuvants›cancer immunotherapy›immunemediated diseasesinvestors and media›overview›press releases›events  presentations›stock information›analyst coverage›financials›sec filings›annuals and proxies›corporate governance›contact uscareers›us job opportunities›eu job opportunities›benefits management team eddie gray chief executive officer and director robert l coffman phd senior vice president and chief scientific officer steven n gersten vice president and general counsel robert janssen chief medical officer and vice president clinical development david novack senior vice president operations and quality michael s ostrach senior vice president chief financial officer and chief business officer cecilia vitug vice president human resources eddie gray chief executive officer and director mr gray joined dynavax as chief executive officer and was appointed to our board in may  most recently mr gray served as the president of pharmaceuticals europe and a member of the corporate executive team at glaxosmithkline plc gsk since  and as senior vice president and general manager of pharmaceuticals uk from  through  prior to the formation of gsk mr gray was with smithkline beecham from  through  serving in various positions of increasing responsibility including vice president and director of antiinfectives marketing in the us vice president and director of the vaccines business unit in the us and vice president and general manager of pharmaceuticals in canada mr gray received a bachelor of science degree in chemistry and management studies from the university of london and an mba from the cranfield school of management in the uk robert l coffman phd senior vice president and chief scientific officer robert l coffman phd is senior vice president and chief scientific officer of dynavax technologies corporation in berkeley ca prior to joining dynavax in  dr coffman was a founding member of the dnax research institute in palo alto ca dr coffman has authored over  scientific publications is a member of the national academy of sciences and the american academy of microbiology and has received a number of prestigious awards for his work with colleague dr tim mosmann he defined the two principal subtypes of helper t cells termed th and th cells and demonstrated the central relationship between their differences in cytokine expression and function dr coffman defined basic mechanisms of tcell regulation in asthma and infectious and parasitic diseases and demonstrated the central role of regulatory cd t cells in preventing inflammatory bowel disease at dynavax dr coffman has pioneered the development of agonists and antagonists for tolllike receptors key recognition receptors in innate immunity steven n gersten vice president and general counsel steven n gersten joined dynavax in  as vice president general counsel and chief ethics and compliance officer prior to joining dynavax he served as global vice president and ethics and compliance officer at abbvie where he helped build the compliance program and organization from  to  he was employed by abbott laboratories where he served as vice president and chief regulatory and compliance counsel and vice president and chief counsel  general counsel to several business units setting global legal strategies and functional plans as well as overseeing the internal legal organization and external counsel prior to joining abbott mr gersten held various positions of increasing responsibility with the us department of justice where he brought enforcement cases on behalf of the fda the law firms howrey and simon and shea and gould and with the us attorney’s office in washington dc mr gersten holds a jd degree from the boston university school of law and a bs degree from boston university school of management robert janssen chief medical officer and vice president clinical development dr janssen was appointed chief medical officer and vice president clinical development in july  he most recently served as dynavaxs vice president medical affairs since november  and was previously senior director clinical development at dynavax from  through  during which time he was extensively involved with phase  clinical development of heplisavb and its us and european licensing applications prior to joining dynavax dr janssen was vice president medical affairs at gilead from  to  where he was responsible for oversight of physician and health care provider education focused on hiv and hepatitis b therapies until  dr janssen spent  years at the us centers for disease control and prevention cdc most recently as the director of the division of hivaids prevention from  to  under his leadership cdc first explored hiv treatment as a mode of hiv prevention and launched several of the earliest phase  trials of preexposure prophylaxis for hiv dr janssen received a bachelor of arts degree with honors in humanities from stanford university and his md degree from the university of southern california he is a neurologist with training in virology at the university of pennsylvania dr janssen has been the beneficiary of numerous honors and awards during his career he has published over  scientific articles in a variety of journals and has served as a reviewer for leading scientific journals david novack senior vice president operations and quality mr novack joined dynavax in march  as senior vice president operations and quality mr novack was formerly with novartis vaccines  diagnostics where he served since  as the global head of technical operations and supply chain for diagnostics and previously from  to  as the global head of vaccine manufacturing strategy prior to novartis mr novack was the vice president business development for vaxin inc a vaccine company from  until  mr novack worked at medimmune serving in several capacities including business development manufacturing contract operations and supply chain operations mr novack received a bs in biology from state university of new york and an mba from columbia university michael s ostrach senior vice president chief financial officer and chief business officer mr ostrach joined dynavax in  as vice president chief business officer and general counsel and became principal financial officer in  and chief financial officer in  from  to  he was chief operating officer chief financial officer and general counsel at threshold pharmaceuticals from  to  mr ostrach was at kosan biosciences most recently as president and chief operating officer mr ostrach began his corporate career at cetus corporation where he served in several capacities between  and  initially as general counsel and finally as senior vice president of corporate affairs and general counsel following the acquisition of cetus by chiron corporation in  mr ostrach became president of chiron technologies he holds a ba from brown university and a jd from stanford law school cecilia vitug vice president human resources ms vitug has been our vice president of human resources since october  she previously served as senior director of human resources and director of human resources since joining us in june  from  to  ms vitug was employed by collagen aesthetics inc where she was director of human resources payroll and administrative services ms vitug brings to dynavax more than  years of human resources and administrative services experience including positions at somatix therapy corporation chiron corporation and wells fargo bank ›our vision›management team›board of directors›dynavax europe›contact contact us    terms  conditions  dynavax technologies corporation all rights reserved dynavax  board of directors search homeabout usour visionmanagement teamboard of directorsdynavax europecontactour sciencetolllike receptorstlr agoniststlr inhibitorspublicationsour pipelineadjuvantshbsagcancer immunotherapysddvpreclinicalimmunemediated diseasesazd asthmainvestors and mediaoverviewpress releasesevents  presentationsstock informationanalyst coveragefinancialssec filingsannuals and proxiescorporate governanceboard of directorscommittee compositioncontact the boardcontact uscareersus job opportunitieseu job opportunitiesbenefits contact us search homeabout us›our vision›management team›board of directors›dynavax europeour science›tolllike receptors›publicationsour pipeline›adjuvants›cancer immunotherapy›immunemediated diseasesinvestors and media›overview›press releases›events  presentations›stock information›analyst coverage›financials›sec filings›annuals and proxies›corporate governance›contact uscareers›us job opportunities›eu job opportunities›benefits board of directors arnold l oronsky phd chairman of the board laura brege francis r cano phd dennis a carson md eddie gray daniel l kisner md peggy v phillips stanley a plotkin md natale “nat” ricciardi arnold l oronsky phd chairman of the board dr oronsky has been a member of our board since november  and became chairman in february  dr oronsky is a managing director with interwest partners a venture capital firm prior to joining interwest partners in  dr oronsky was vice president of discovery research for the lederle laboratories division of american cyanamid a pharmaceutical company from  until  dr oronsky was head of the inflammation allergy and immunology research program at cibageigy pharmaceutical company dr oronsky also serves as a senior lecturer in the department of medicine at the johns hopkins medical school dr oronsky has won numerous grants and awards and has published over  scientific articles he received his phd from columbia university college of physicians and surgeons and his ab from new york university laura brege ms brege has been a member of our board since february   she is president and chief executive officer of nodality inc  she has over  years of executive management experience in the pharmaceutical biotechnology and venture capital industries prior to joining nodality in  ms brege held several seniorlevel positions at onyx pharmaceuticals inc including executive vice president and chief operating officer while at onyx she led multiple functions including commercialization strategic planning corporate development and medical scientific and government affairs prior to onyx ms brege was a general partner at red rock capital management a venture capital firm specializing in early stage financing for technology companies  previously ms brege was svp and chief financial officer at cor therapeutics helping build the company from an early stage rd company through commercial launch of a successful cardiovascular product earlier in her career she served as chief financial officer at flextronics inc and treasurer of the cooper companies she serves on the board of directors of acadia pharmaceuticals inc aratana therapeutics inc and pacira pharmaceuticals inc  ms brege earned her undergraduate degrees from ohio university honors tutorial college and her mba degree from the university of chicago francis r cano phd dr cano was appointed to our board in november  dr cano is president and founder of cano biotech corp a consulting firm focusing on the vaccine business and also serves on the boards of biomerica inc a developer and manufacturer of diagnostic products and arbor vita corporation a biopharmaceutical company from  to  dr cano was president and chief operating officer for aviron a biopharmaceutical company which was later acquired by medimmune in  as a cofounder of aviron he completed two rounds of venture financing a licensing agreement with smithkline biologicals and inlicensed flumist influenza vaccine from the national institutes of health for  years dr cano worked with the lederle laboratories division of american cyanamid most recently as vice president and general manager of the biologicals unit he earned a phd in microbiology from pennsylvania state university served as a research associate at rutgers institute of microbiology and holds a ms in microbiology and a bs in biology from st johns university dennis a carson md dr carson has been a member of our board since december  dr carson is a noted researcher in the fields of autoimmune and immunodeficiency diseases and is codiscoverer with dr eyal raz of the immunostimulatory sequences iss that form the basis of our technology he has played key roles in the founding of vical inc a gene therapy company idec pharmaceuticals a biopharmaceutical company and triangle pharmaceuticals a pharmaceutical company dr carson is a director of biomerica inc dr carson is director of the rebecca and john  moores cancer center at the university of california san diego and has been a professor in the department of medicine at the university of california san diego since  he is a member of the national academy of sciences the american academy of arts and sciences and the institute of medicine as well as the american association for cancer research the american society for clinical investigation the american society of hematology and the association of american physicians he received his md from columbia university and his ba from haverford college dr carson completed his residency in internal medicine and a postdoctoral fellowship at the university of california san diego eddie gray mr gray joined dynavax as chief executive officer and was appointed to our board in may  most recently mr gray served as the president of pharmaceuticals europe at glaxosmithkline plc gsk since  and as senior vice president and general manager of pharmaceuticals uk from  through  prior to the formation of gsk mr gray was with smithkline beecham from  through  serving in various positions of increasing responsibility including vice president and director of antiinfectives marketing in the us vice president and director of the vaccines business unit in the us and vice president and general manager of pharmaceuticals in canada mr gray received a bachelor of science degree in chemistry and management university of london and an mba from the cranfield school of management in the uk daniel l kisner md dr kisner has been a member of our board since july  he most recently served as a partner at aberdare ventures and prior to that as president and ceo of caliper technologies leading its evolution from a startup focused on microfluidic labonchip technology to a publicly traded commercial organization prior to caliper he was the president and chief operating officer of isis pharmaceuticals inc a biomedical pharmaceutical company previously dr kisner was division vice president of pharmaceutical development for abbott laboratories and vice president of clinical research and development at smithkline beckman pharmaceuticals in addition he held a tenured position in the division of oncology at the university of texas san antonio school of medicine and is certified by the american board of internal medicine in internal medicine and medical oncology dr kisner serves as chairman of the board for tekmira pharmaceuticals a biopharmaceutical company he holds a ba from rutgers university and an md from georgetown university peggy v phillips ms phillips has been a member of our board since august  ms phillips currently also serves on the board of directors of portola pharmaceuticals a biopharmaceutical company and she served on the board of western wireless a cellular network operator from  until the acquisition of the company by alltel in mid from  until  ms phillips served on the board of the naval academy foundation from  until  she served on the board of directors of immunex corporation a biotechnology company and from  she served as the chief operating officer until the company was acquired by amgen in  during her career at immunex she held positions of increasing responsibility in research development manufacturing sales and marketing as senior vice president for pharmaceutical development and general manager for enbrel® she was responsible for clinical development and regulatory affairs as well as the launch sales and marketing of the product prior to joining immunex ms phillips worked at miles laboratories ms phillips holds a bs and a ms in microbiology from the university of idaho stanley a plotkin md dr plotkin has been a member of our board since august  dr plotkin is emeritus professor of the university of pennsylvania until  he was professor of pediatrics and microbiology at the university of pennsylvania and professor of virology at the wistar institute and at the same time director of infectious diseases and senior physician at the childrens hospital of philadelphia in  dr plotkin left the university to join the vaccine manufacturer pasteurmérieuxconnaught today sanofi pasteur where for seven years he was medical and scientific director based at marneslacoquette outside paris until  he was an executive advisor to sanofi pasteur dr plotkins career included internship at cleveland metropolitan general hospital residency in pediatrics at the childrens hospital of philadelphia and the hospital for sick children in london and three years in the epidemic intelligence service of the centers for disease control of the us public health service he has been chairman of the infectious diseases committee and the aids task force of the american academy of pediatrics liaison member of the advisory committee on immunization practices and chairman of the microbiology and infectious diseases research committee of the national institutes of health natale “nat” ricciardi mr ricciardi was appointed to our board in june  mr ricciardi spent his entire year biopharmaceutical career at pfizer inc retiring in  as a member of the pfizer executive leadership team while holding the positions of president pfizer global manufacturing and senior vice president of pfizer inc nat was directly responsible for all of pfizers internal and external supply organization a global enterprise that grew to more than  manufacturing facilities supplying small and large molecule pharmaceuticals vaccines consumer nutrition and animal health products mr ricciardi maintained responsibility for global manufacturing activities from  through  previously from  to  he had oversight for pfizers us manufacturing operations and from  to  was vice president of manufacturing for pfizers animal health group mr ricciardi served on the boards of the national association of manufacturers and mediacom communications corporation until its privatization in  he is currently a member of the boards of prestige brands holdings inc and the st century foundation of the city college of new york nat earned a degree in chemical engineering from the city college of new york and an mba in finance and international business from fordham university ›our vision›management team›board of directors›dynavax europe›contact contact us    terms  conditions  dynavax technologies corporation all rights reserved dynavax technologies corp dvaxph company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile dynavax technologies corp dvaxph related topics stocksstock screenerhealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse dvaxph on philadelphia stock exchange usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description dynavax technologies corporation dynavax incorporated on november   is a clinicalstage immunotherapy company focused on leveraging the bodys innate and adaptive immune responses through tolllike receptor tlr stimulation the companys product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of hepatitis b and as a disease modifying therapy for asthma the companys pipeline of product candidates includes heplisavb azd sd dv dvf and dv dvf is indicated for the treatment of liver tumors dv targets tlr  and  agonist for multiple malignancies dvf and dv are in preclinical stage of developmentheplisavbthe companys product candidate heplisavb is an investigational adult hepatitis b vaccine heplisavb combines  a tlr agonist adjuvant and recombinant hepatitis b surface antigen rhbsag heplisavb is in phase iii of its clinical trialsazdazd is being developed for the treatment of asthma pursuant to a collaboration with astrazeneca ab astrazeneca azd is designed to change the basic immune response to environmental allergens such as house dust and pollens leading to prolonged reduction in asthma symptoms by converting the response from one primarily mediated by type helper thymus t cells to type helper t cells azd is in phase ii of its clinical trialssdsd is an investigational tlr agonist designed to elicit a potent and focused immune response to cancer by targeting tlr in both the early and late endosomes of plasmacytoid dendritic cells sd is intended to stimulate multiple mechanisms of tumor killing sd is indicated for melanoma head and neck squamous cell carcinoma and multiple malignancies for melanoma and head and neck squamous cell carcinoma sd is being tested in phase ii and for other multiple malignancies it is being tested in phase idvdv is an investigational tlr agonist designed specifically for focused delivery to primary lung tumors and lung metastases dv is similar in biological activity and mechanism of action to sd but has been optimized for administration as an aerosol dv targets nonsmall cell lung cancerthe company competes with aduro biotech inc idera pharmaceuticals inc immune design corp and checkmate pharmaceuticals inc » full overview of dvaxph company address dynavax technologies corp  th st ste berkeley   ca    p f  company web links home page officers  directors name compensation arnold oronsky  eddie gray  michael ostrach  robert coffman  david novack  » more officers  directors dynavax technologies corp news correctedbriefpoint asset management reports  pct passive stake in dynavax technologies corp jun   briefdynavax presents updated data for sd in combination with keytruda jun   briefdynavax reports q loss per share  may   briefdynavax announces fda acceptance feb   » more dvaxph news related topics stocksstock screenerhealthcarebiotechnology  medical research dynavax  home search homeabout usour visionmanagement teamboard of directorsdynavax europecontactour sciencetolllike receptorstlr agoniststlr inhibitorspublicationsour pipelineadjuvantshbsagcancer immunotherapysddvpreclinicalimmunemediated diseasesazd asthmainvestors and mediaoverviewpress releasesevents  presentationsstock informationanalyst coveragefinancialssec filingsannuals and proxiescorporate governanceboard of directorscommittee compositioncontact the boardcontact uscareersus job opportunitieseu job opportunitiesbenefits contact us search homeabout us›our vision›management team›board of directors›dynavax europeour science›tolllike receptors›publicationsour pipeline›adjuvants›cancer immunotherapy›immunemediated diseasesinvestors and media›overview›press releases›events  presentations›stock information›analyst coverage›financials›sec filings›annuals and proxies›corporate governance›contact uscareers›us job opportunities›eu job opportunities›benefits experts in tlr biology we are developing immunotherapies based on cuttingedge tolllike receptor tlr biology and its ability to modulate the immune system learn more   cancer immunotherapy through our expertise in tlr biology we are developing compounds designed to stimulate multiple innate mechanisms of tumor killing and development of immune memory associated with tumorspecific antigens learn more   ‹ › cancer immunotherapy utilizing tolllike receptor biology to leverage the power of the bodys immune response to stimulate multiple innate mechanisms activating a cascade of antitumor activities learn more ›    hepatitis b vaccine hbsag is an investigational adult hepatitis b vaccine that combines hepatitis b surface antigen with  our proprietary tlr agonist learn more › news jun dynavax presents updated data for sd in combination with keytrudar pembrolizumab highlighting an orr in  out of  patients naive to an antipd or antipdl therapy may dynavax to present data on sd in combination with keytrudar at the  american society of clinical oncology asco annual meeting may dynavax reports first quarter  financial results view all news our values at dynavax we are proud of the work we do our corporate values provide the foundation of our culture and how we operate as a company learn more › contact us    terms  conditions  dynavax technologies corporation all rights reserved dvax stock price  dynavax technologies corp stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers ctas  cof  etfc  syf  hp  isrg  hban  chk  latest newsall times eastern p updated ‘game of thrones’ the four biggest takeaways from stormborn’ p updated why you’re more likely to die in an accident during the summer months p updated these wealthy parents spend  for summer camps so their kids can be ‘normal’ p updated  totally avoidable reasons why millennials can’t have nice things or save any money p updated how elon musk and shorter commutes could transform people’s lives p updated john mccain is a war hero — but think twice before saying he’s ‘battling’ cancer p updated the dark side of cruises p updated at least  dead after overheated tractortrailer found outside texas walmart p ‘full transparency’ doesn’t mean what scaramucci apparently thinks it means p stocks brace for volatility in earnings deluge fed meeting looms to be replaced home investing quotes stocks united states dvax overview compare quotes stock screener earnings calendar sectors nasdaq dvax us nasdaq join td ameritrade find a broker dynavax technologies corp watchlist createdvaxalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume m  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones update dynavax shares reverse premarket losses to open flat mar   at  am et by ciara linnane dynavax shares fall  premarket after it releases data from melanoma trial mar   at  am et by ciara linnane dynavax stock surges  on new fda review of hep b vaccine and trump statements about fda deregulation mar   at  pm et by emma court dynavaxs stock plunges after disappointing fda response to hepb treatment nov   at  am et by tomi kilgore dynavaxs stock plunges  premarket after fda asks for more info on hepatitis treatment nov   at  am et by tomi kilgore dynavax stock drops then gains  after canceled fda drug review confounds investors sep   at  pm et by emma court dynavax downgraded to sector perform from outperform at rbc capital apr   at  am et by tomi kilgore  stocks to watch sep   at  pm et by harry boxer dow industrials hesitate at the day average jul   at  am et by michael ashbaugh ascena retail shares rally after hours sep   at  pm et by wallace witkowski fda dynavax hep b vaccine needs more evaluation feb   at  am et dynavax tech down  in premarket dec   at  am et by steve gelsi dynavax tech off  in premarket trades nov   at  am et by steve gelsi dynavax tech falls  in premarket trades nov   at  am et by steve gelsi wednesday’s biggest gaining and declining stocks may   at  pm et by marketwatch dynavax tumbles  on stock offer pricing may   at  pm et by val brickates kennedy dynavax jumps  on fda update jul   at  am et by val brickates kennedy dynavax plunges  on mixed study results jul   at  am et by val brickates kennedy tuesday’s biggest gaining and declining stocks sep   at  pm et by marketwatch drug stocks trend lower pfizer dynavax gain dec   at  pm et by val brickates kennedy consumer confidence seen to be waning a new indicator is forecasting a decline for july ahead of the conference board report jul   at  am et on barrons online less is not more for biotech investors jan   at  pm et on the wall street journal stocks to watch mcdonalds apricus dynavax jun   at  am et on the wall street journal dynavax vaccine needs further evaluation feb   at  pm et on the wall street journal stocks to watch barnes  noble elan corp affymax feb   at  am et on the wall street journal stocks to watch schiff nutrition penn national gaming gap nov   at  am et on the wall street journal cfo moves dynavax say media sacrecoure minerals aug   at  pm et on the wall street journal stocks to watch macys green mountain demand media may   at  am et on the wall street journal flagstar bancorp dynavax technologies biggest price decliners fbc dvax may   at  pm et on the wall street journal flagstar bancorp dynavax technologies biggest price decliners fbc dvax may   at  pm et on the wall street journal xerium technologies dynavax technologies biggest price decliners xrm dvax mar   at  pm et on the wall street journal xerium technologies dynavax technologies biggest price decliners xrm dvax mar   at  pm et on the wall street journal marketbeat selling tellabs jan   at  am et on the wall street journal marketbeat a cure for what ills nov   at  am et on the wall street journal marketbeat about that jobs report oct   at  pm et on the wall street journal bids  offers cutrate drugs feb   at  am et on the wall street journal recent news other news press releases stocks to watch next week stocks to watch next week jul   at  am et on seeking alpha q biotech catalyst watch key pdufas part  q biotech catalyst watch key pdufas part  jul   at  pm et on seeking alpha options traders expect huge moves in dynavax technologies dvax stock dynavax technologies dvax needs investors to pay close attention to the stock based on moves in the options market lately jul   at  am et on zackscom  biotech stocks with gamechanging dates in q  biotech stocks with gamechanging dates in q jul   at  pm et on investorplacecom biotech forum daily digest  biotech fritters away some gains  fda calendar events in july biotech forum daily digest  biotech fritters away some gains  fda calendar events in july jul   at  am et on seeking alpha  biotech stocks with major catalysts in july jun   at  pm et on motley fool vbi vaccines phase  catalyst vbi vaccines phase  catalyst jun   at  pm et on seeking alpha  more small biotechs for the rest of   more small biotechs for the rest of  jun   at  pm et on seeking alpha  stocks that could double your money jun   at  am et on motley fool dynavax technologies dvax catches eye stock gains  dynavax technologies corporation dvax shares rose almost  in the last trading session jun   at  am et on zackscom my biggest mistake sticking with gilead too long bret jensen my biggest mistake sticking with gilead too long bret jensen jun   at  am et on seeking alpha will these cuttingedge cancer killers reignite the biotech rally the biotech industry always a highly technical conundrum for investors might currently pose an even greater challenge — and offer even greater risks — than usual early industry innovators like amgen amgn biogen biib and gilead sciences gild currently find themselves in big trouble according to loncar investments chief executive brad loncar largely as victims of their own success but cancer and rare disease specialists kite pharma jun   at  am et on investors business daily introducing the future growth portfolio introducing the future growth portfolio jun   at  pm et on seeking alpha an option play on dynavax technologies an option play on dynavax technologies jun   at  am et on seeking alpha seeking alpha interviews bret jensen seeking alpha interviews bret jensen jun   at  am et on seeking alpha dynavax an analysis of the approvability of heplisavb dynavax an analysis of the approvability of heplisavb jun   at  pm et on seeking alpha dynavax dvax looks good stock gains  in session dynavax technologies corporation dvax moved big last session as its shares rose almost  on the day jun   at  am et on zackscom wendy’s co wen and kate spade  co kate lead  activist investor filings wendy’s co wen and kate spade  co kate lead  activist investor filings jun   at  am et on investorplacecom  bold biotech predictions for the nd half of   bold biotech predictions for the nd half of  jun   at  am et on seeking alpha midafternoon market update loxo oncology surges after positive results from larotrectinib trial microbot medical shares plunge midafternoon market update loxo oncology surges after positive results from larotrectinib trial microbot medical shares plunge jun   at  pm et on benzingacom lifshitz  miller llp files amended shareholder derivative lawsuit on behalf of dynavax technologies corporation lifshitz  miller llp files amended shareholder derivative lawsuit on behalf of dynavax technologies corporation jun   at  pm et on pr newswire  prf loncar cancer immunotherapy index conducts semiannual rebalance loncar cancer immunotherapy index conducts semiannual rebalance jun   at  am et on businesswire  bzx breakfast technical briefing on biotech stocks  opko health pain therapeutics trevena and dynavax technologies breakfast technical briefing on biotech stocks  opko health pain therapeutics trevena and dynavax technologies jun   at  am et on pr newswire  prf todays research reports on stocks to watch dynavax technologies and gigamon todays research reports on stocks to watch dynavax technologies and gigamon jun   at  am et on accesswire dynavax presents updated data for sd in combination with keytrudar pembrolizumab highlighting an orr in  out of  patients naive to an antipd or antipdl therapy dynavax presents updated data for sd in combination with keytrudar pembrolizumab highlighting an orr in  out of  patients naive to an antipd or antipdl therapy jun   at  pm et on marketwired todays research reports on stocks to watch aeterna zentaris and dynavax technologies todays research reports on stocks to watch aeterna zentaris and dynavax technologies may   at  am et on accesswire dynavax to present data on sd in combination with keytrudar at the  american society of clinical oncology asco annual meeting dynavax to present data on sd in combination with keytrudar at the  american society of clinical oncology asco annual meeting may   at  am et on marketwired biotech stocks on investors radar  progenics pharma dynavax technologies intrexon and heat biologics biotech stocks on investors radar  progenics pharma dynavax technologies intrexon and heat biologics may   at  am et on pr newswire  prf dynavax reports first quarter  financial results dynavax reports first quarter  financial results may   at  am et on marketwired dynavax announces fda advisory committee meeting to review heplisavb apr   at  am et on marketwired dynavax announces upcoming data presentations for three tlr agonist programs at the  american association for cancer research annual meeting mar   at  am et on marketwired technical reports on biotech stocks  nektar therapeutics seattle genetics dynavax technologies and biomarin pharma mar   at  am et on pr newswire  prf dynavax reports fourth quarter and year end  financial results and company update mar   at  am et on marketwired dynavax presents promising clinical data from lead immunooncology candidate sd at the international congress on targeted anticancer therapies mar   at  am et on marketwired biotechs outlook strengthens after president trumps speech todays reports on dynavax technologies and lexicon pharmaceuticals mar   at  am et on accesswire dynavax to present at the cowen and company th annual health care conference mar   at  am et on marketwired dynavax announces fda acceptance for review of its complete response to november  crl and pdufa action date for heplisavbtm feb   at  pm et on marketwired dynavax to present at the  rbc capital markets global healthcare conference feb   at  am et on marketwired shareholder alert lundin law pc announces securities class action lawsuit against dynavax technologies corporation and encourages investors with losses to contact the firm jan   at  am et on accesswire upcoming deadline levi  korsinsky llp reminds shareholders of dynavax technologies corporation of a class action lawsuit and a lead plaintiff deadline of january   – dvax jan   at  am et on businesswire  bzx dynavax technologies corp dynavax technologies corp is a clinicalstage biopharmaceutical company that uses tolllike receptor biology to discover and develop novel vaccines and therapeutics the companys development programs are organized under its three areas of focus vaccine adjuvants cancer immunotherapy and autoimmune and inflammatory diseases its lead product candidate is heplisav a phase iii investigational adult hepatitis b vaccine the companys other products under pipeline are sd dv autoimmune disease and azd asthma therapy dynavax technologies was founded by lawrence m lichtenstein dennis a carson and eyal raz on august   and is headquartered in berkeley ca see full profile analyst ratings sell under hold over buy number of ratings  full ratings dynavax glaxosmithkline battling in same industry who will win feb   at  pm et on benzingacom william blairs best ideas in a volatile market aug   at  pm et on benzingacom jp morgan upgrades dynavax technologies to overweight mar   at  am et on benzingacom competitors name chg  market cap gilead sciences inc  b biogen inc  b momenta pharmaceuticals inc  b idera pharmaceuticals inc  m astrazeneca plc adr  b competitor data provided by partner content trending tickers powered by bzun  mrk  gbtc  googl  nyt  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert tokyo markets close in currencies europe markets london markets stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert tokyo markets close in currencies europe markets london markets stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert tokyo markets close in currencies europe markets london markets stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  dvax stock price  dynavax technologies corp stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers ctas  cof  etfc  syf  hp  isrg  hban  chk  latest newsall times eastern p updated ‘game of thrones’ the four biggest takeaways from stormborn’ p updated why you’re more likely to die in an accident during the summer months p updated these wealthy parents spend  for summer camps so their kids can be ‘normal’ p updated  totally avoidable reasons why millennials can’t have nice things or save any money p updated how elon musk and shorter commutes could transform people’s lives p updated john mccain is a war hero — but think twice before saying he’s ‘battling’ cancer p updated the dark side of cruises p updated at least  dead after overheated tractortrailer found outside texas walmart p ‘full transparency’ doesn’t mean what scaramucci apparently thinks it means p stocks brace for volatility in earnings deluge fed meeting looms to be replaced home investing quotes stocks united states dvax overview compare quotes stock screener earnings calendar sectors nasdaq dvax us nasdaq join td ameritrade find a broker dynavax technologies corp watchlist createdvaxalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume m  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones update dynavax shares reverse premarket losses to open flat mar   at  am et by ciara linnane dynavax shares fall  premarket after it releases data from melanoma trial mar   at  am et by ciara linnane dynavax stock surges  on new fda review of hep b vaccine and trump statements about fda deregulation mar   at  pm et by emma court dynavaxs stock plunges after disappointing fda response to hepb treatment nov   at  am et by tomi kilgore dynavaxs stock plunges  premarket after fda asks for more info on hepatitis treatment nov   at  am et by tomi kilgore dynavax stock drops then gains  after canceled fda drug review confounds investors sep   at  pm et by emma court dynavax downgraded to sector perform from outperform at rbc capital apr   at  am et by tomi kilgore  stocks to watch sep   at  pm et by harry boxer dow industrials hesitate at the day average jul   at  am et by michael ashbaugh ascena retail shares rally after hours sep   at  pm et by wallace witkowski fda dynavax hep b vaccine needs more evaluation feb   at  am et dynavax tech down  in premarket dec   at  am et by steve gelsi dynavax tech off  in premarket trades nov   at  am et by steve gelsi dynavax tech falls  in premarket trades nov   at  am et by steve gelsi wednesday’s biggest gaining and declining stocks may   at  pm et by marketwatch dynavax tumbles  on stock offer pricing may   at  pm et by val brickates kennedy dynavax jumps  on fda update jul   at  am et by val brickates kennedy dynavax plunges  on mixed study results jul   at  am et by val brickates kennedy tuesday’s biggest gaining and declining stocks sep   at  pm et by marketwatch drug stocks trend lower pfizer dynavax gain dec   at  pm et by val brickates kennedy consumer confidence seen to be waning a new indicator is forecasting a decline for july ahead of the conference board report jul   at  am et on barrons online less is not more for biotech investors jan   at  pm et on the wall street journal stocks to watch mcdonalds apricus dynavax jun   at  am et on the wall street journal dynavax vaccine needs further evaluation feb   at  pm et on the wall street journal stocks to watch barnes  noble elan corp affymax feb   at  am et on the wall street journal stocks to watch schiff nutrition penn national gaming gap nov   at  am et on the wall street journal cfo moves dynavax say media sacrecoure minerals aug   at  pm et on the wall street journal stocks to watch macys green mountain demand media may   at  am et on the wall street journal flagstar bancorp dynavax technologies biggest price decliners fbc dvax may   at  pm et on the wall street journal flagstar bancorp dynavax technologies biggest price decliners fbc dvax may   at  pm et on the wall street journal xerium technologies dynavax technologies biggest price decliners xrm dvax mar   at  pm et on the wall street journal xerium technologies dynavax technologies biggest price decliners xrm dvax mar   at  pm et on the wall street journal marketbeat selling tellabs jan   at  am et on the wall street journal marketbeat a cure for what ills nov   at  am et on the wall street journal marketbeat about that jobs report oct   at  pm et on the wall street journal bids  offers cutrate drugs feb   at  am et on the wall street journal recent news other news press releases stocks to watch next week stocks to watch next week jul   at  am et on seeking alpha q biotech catalyst watch key pdufas part  q biotech catalyst watch key pdufas part  jul   at  pm et on seeking alpha options traders expect huge moves in dynavax technologies dvax stock dynavax technologies dvax needs investors to pay close attention to the stock based on moves in the options market lately jul   at  am et on zackscom  biotech stocks with gamechanging dates in q  biotech stocks with gamechanging dates in q jul   at  pm et on investorplacecom biotech forum daily digest  biotech fritters away some gains  fda calendar events in july biotech forum daily digest  biotech fritters away some gains  fda calendar events in july jul   at  am et on seeking alpha  biotech stocks with major catalysts in july jun   at  pm et on motley fool vbi vaccines phase  catalyst vbi vaccines phase  catalyst jun   at  pm et on seeking alpha  more small biotechs for the rest of   more small biotechs for the rest of  jun   at  pm et on seeking alpha  stocks that could double your money jun   at  am et on motley fool dynavax technologies dvax catches eye stock gains  dynavax technologies corporation dvax shares rose almost  in the last trading session jun   at  am et on zackscom my biggest mistake sticking with gilead too long bret jensen my biggest mistake sticking with gilead too long bret jensen jun   at  am et on seeking alpha will these cuttingedge cancer killers reignite the biotech rally the biotech industry always a highly technical conundrum for investors might currently pose an even greater challenge — and offer even greater risks — than usual early industry innovators like amgen amgn biogen biib and gilead sciences gild currently find themselves in big trouble according to loncar investments chief executive brad loncar largely as victims of their own success but cancer and rare disease specialists kite pharma jun   at  am et on investors business daily introducing the future growth portfolio introducing the future growth portfolio jun   at  pm et on seeking alpha an option play on dynavax technologies an option play on dynavax technologies jun   at  am et on seeking alpha seeking alpha interviews bret jensen seeking alpha interviews bret jensen jun   at  am et on seeking alpha dynavax an analysis of the approvability of heplisavb dynavax an analysis of the approvability of heplisavb jun   at  pm et on seeking alpha dynavax dvax looks good stock gains  in session dynavax technologies corporation dvax moved big last session as its shares rose almost  on the day jun   at  am et on zackscom wendy’s co wen and kate spade  co kate lead  activist investor filings wendy’s co wen and kate spade  co kate lead  activist investor filings jun   at  am et on investorplacecom  bold biotech predictions for the nd half of   bold biotech predictions for the nd half of  jun   at  am et on seeking alpha midafternoon market update loxo oncology surges after positive results from larotrectinib trial microbot medical shares plunge midafternoon market update loxo oncology surges after positive results from larotrectinib trial microbot medical shares plunge jun   at  pm et on benzingacom lifshitz  miller llp files amended shareholder derivative lawsuit on behalf of dynavax technologies corporation lifshitz  miller llp files amended shareholder derivative lawsuit on behalf of dynavax technologies corporation jun   at  pm et on pr newswire  prf loncar cancer immunotherapy index conducts semiannual rebalance loncar cancer immunotherapy index conducts semiannual rebalance jun   at  am et on businesswire  bzx breakfast technical briefing on biotech stocks  opko health pain therapeutics trevena and dynavax technologies breakfast technical briefing on biotech stocks  opko health pain therapeutics trevena and dynavax technologies jun   at  am et on pr newswire  prf todays research reports on stocks to watch dynavax technologies and gigamon todays research reports on stocks to watch dynavax technologies and gigamon jun   at  am et on accesswire dynavax presents updated data for sd in combination with keytrudar pembrolizumab highlighting an orr in  out of  patients naive to an antipd or antipdl therapy dynavax presents updated data for sd in combination with keytrudar pembrolizumab highlighting an orr in  out of  patients naive to an antipd or antipdl therapy jun   at  pm et on marketwired todays research reports on stocks to watch aeterna zentaris and dynavax technologies todays research reports on stocks to watch aeterna zentaris and dynavax technologies may   at  am et on accesswire dynavax to present data on sd in combination with keytrudar at the  american society of clinical oncology asco annual meeting dynavax to present data on sd in combination with keytrudar at the  american society of clinical oncology asco annual meeting may   at  am et on marketwired biotech stocks on investors radar  progenics pharma dynavax technologies intrexon and heat biologics biotech stocks on investors radar  progenics pharma dynavax technologies intrexon and heat biologics may   at  am et on pr newswire  prf dynavax reports first quarter  financial results dynavax reports first quarter  financial results may   at  am et on marketwired dynavax announces fda advisory committee meeting to review heplisavb apr   at  am et on marketwired dynavax announces upcoming data presentations for three tlr agonist programs at the  american association for cancer research annual meeting mar   at  am et on marketwired technical reports on biotech stocks  nektar therapeutics seattle genetics dynavax technologies and biomarin pharma mar   at  am et on pr newswire  prf dynavax reports fourth quarter and year end  financial results and company update mar   at  am et on marketwired dynavax presents promising clinical data from lead immunooncology candidate sd at the international congress on targeted anticancer therapies mar   at  am et on marketwired biotechs outlook strengthens after president trumps speech todays reports on dynavax technologies and lexicon pharmaceuticals mar   at  am et on accesswire dynavax to present at the cowen and company th annual health care conference mar   at  am et on marketwired dynavax announces fda acceptance for review of its complete response to november  crl and pdufa action date for heplisavbtm feb   at  pm et on marketwired dynavax to present at the  rbc capital markets global healthcare conference feb   at  am et on marketwired shareholder alert lundin law pc announces securities class action lawsuit against dynavax technologies corporation and encourages investors with losses to contact the firm jan   at  am et on accesswire upcoming deadline levi  korsinsky llp reminds shareholders of dynavax technologies corporation of a class action lawsuit and a lead plaintiff deadline of january   – dvax jan   at  am et on businesswire  bzx dynavax technologies corp dynavax technologies corp is a clinicalstage biopharmaceutical company that uses tolllike receptor biology to discover and develop novel vaccines and therapeutics the companys development programs are organized under its three areas of focus vaccine adjuvants cancer immunotherapy and autoimmune and inflammatory diseases its lead product candidate is heplisav a phase iii investigational adult hepatitis b vaccine the companys other products under pipeline are sd dv autoimmune disease and azd asthma therapy dynavax technologies was founded by lawrence m lichtenstein dennis a carson and eyal raz on august   and is headquartered in berkeley ca see full profile analyst ratings sell under hold over buy number of ratings  full ratings dynavax glaxosmithkline battling in same industry who will win feb   at  pm et on benzingacom william blairs best ideas in a volatile market aug   at  pm et on benzingacom jp morgan upgrades dynavax technologies to overweight mar   at  am et on benzingacom competitors name chg  market cap gilead sciences inc  b biogen inc  b momenta pharmaceuticals inc  b idera pharmaceuticals inc  m astrazeneca plc adr  b competitor data provided by partner content trending tickers powered by bzun  mrk  gbtc  googl  nyt  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience dvax key statistics  dynavax technologies corp financial ratios  marketwatch bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close dynavax technologies corp nasdaq dvax go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus dynavax technologies corp after hours  quotes are delayed by  min jul    pm dvax quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description dynavax technologies corp is a clinicalstage biopharmaceutical company that uses tolllike receptor biology to discover and develop novel vaccines and therapeutics the companys development programs are organized under its three areas of focus vaccine adjuvants cancer immunotherapy and autoimm dynavax technologies corp is a clinicalstage biopharmaceutical company that uses tolllike receptor biology to discover and develop novel vaccines and therapeutics the companys development programs are organized under its three areas of focus vaccine adjuvants cancer immunotherapy and autoimmune and inflammatory diseases its lead product candidate is heplisav a phase iii investigational adult hepatitis b vaccine the companys other products under pipeline are sd dv autoimmune disease and azd asthma therapy dynavax technologies was founded by lawrence m lichtenstein dennis a carson and eyal raz on august   and is headquartered in berkeley ca valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title mr eddie j gray   chief executive officer  director mr david f novack   senior vice presidentoperations  quality mr michael s ostrach   cfo secretary chief business officer  svp dr robert janssen   chief medical officer  vpclinical development dr robert l coffman   chief scientific officer  senior vice president insider actions – purchase – sale  – number of transactions  newslatestcompanyusdvax marketwatch news on dvax update dynavax shares reverse premarket losses to open flat  am march    ciara linnane dynavax shares fall  premarket after it releases data from melanoma trial  am march    ciara linnane dynavax stock surges  on new fda review of hep b vaccine and trump statements about fda deregulation  pm march    emma court dynavaxs stock plunges after disappointing fda response to hepb treatment  am nov    tomi kilgore dynavaxs stock plunges  premarket after fda asks for more info on hepatitis treatment  am nov    tomi kilgore dynavax stock drops then gains  after canceled fda drug review confounds investors  pm sept    emma court dynavax downgraded to sector perform from outperform at rbc capital  am april    tomi kilgore  stocks to watch  pm sept    the trading deck dow industrials hesitate at the day average  am july    michael ashbaugh ascena retail shares rally after hours  pm sept    wallace witkowski fda dynavax hep b vaccine needs more evaluation  am feb    marketwatchcom dynavax tech down  in premarket  am dec    steve gelsi dynavax tech off  in premarket trades  am nov    steve gelsi dynavax tech falls  in premarket trades  am nov    steve gelsi wednesday’s biggest gaining and declining stocks  pm may    marketwatch dynavax tumbles  on stock offer pricing  pm may    val brickates kennedy dynavax jumps  on fda update  am july    val brickates kennedy dynavax plunges  on mixed study results  am july    val brickates kennedy tuesday’s biggest gaining and declining stocks  pm sept    marketwatch drug stocks trend lower pfizer dynavax gain  pm dec    val brickates kennedy loading more headlines newsnonmarketwatchcompanyusdvax other news on dvax stocks to watch next week  am july    seeking alpha q biotech catalyst watch key pdufas part   pm july    seeking alpha options traders expect huge moves in dynavax technologies dvax stock  am july    zackscom  biotech stocks with gamechanging dates in q  pm july    investorplacecom biotech forum daily digest  biotech fritters away some gains  fda calendar events in july  am july    seeking alpha  biotech stocks with major catalysts in july  pm june    motley fool vbi vaccines phase  catalyst  pm june    seeking alpha  more small biotechs for the rest of   pm june    seeking alpha  stocks that could double your money  am june    motley fool dynavax technologies dvax catches eye stock gains   am june    zackscom my biggest mistake sticking with gilead too long bret jensen  am june    seeking alpha introducing the future growth portfolio  pm june    seeking alpha will these cuttingedge cancer killers reignite the biotech rally  am june    investors business daily an option play on dynavax technologies  am june    seeking alpha seeking alpha interviews bret jensen  am june    seeking alpha dynavax an analysis of the approvability of heplisavb  pm june    seeking alpha wendy’s co wen and kate spade  co kate lead  activist investor filings  am june    investorplacecom  bold biotech predictions for the nd half of   am june    seeking alpha dynavax dvax looks good stock gains  in session  am june    zackscom midafternoon market update loxo oncology surges after positive results from larotrectinib trial microbot medical shares plunge  pm june    benzingacom loading more headlines at a glance dynavax technologies corp  seventh street suite  berkeley california  phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue m net income m  sales growth  employees  annual report for dvax newspressreleasecompanyusdvax press releases on dvax lifshitz  miller llp files amended shareholder derivative lawsuit on behalf of dynavax technologies corporation  pm june    pr newswire  prf loncar cancer immunotherapy index conducts semiannual rebalance  am june    businesswire  bzx breakfast technical briefing on biotech stocks  opko health pain therapeutics trevena and dynavax technologies  am june    pr newswire  prf todays research reports on stocks to watch dynavax technologies and gigamon  am june    accesswire dynavax presents updated data for sd in combination with keytrudar pembrolizumab highlighting an orr in  out of  patients naive to an antipd or antipdl therapy  pm june    marketwired todays research reports on stocks to watch aeterna zentaris and dynavax technologies  am may    accesswire dynavax to present data on sd in combination with keytrudar at the  american society of clinical oncology asco annual meeting  am may    marketwired biotech stocks on investors radar  progenics pharma dynavax technologies intrexon and heat biologics  am may    pr newswire  prf dynavax reports first quarter  financial results  am may    marketwired dynavax announces fda advisory committee meeting to review heplisavb  am april    marketwired dynavax announces upcoming data presentations for three tlr agonist programs at the  american association for cancer research annual meeting  am march    marketwired technical reports on biotech stocks  nektar therapeutics seattle genetics dynavax technologies and biomarin pharma  am march    pr newswire  prf dynavax reports fourth quarter and year end  financial results and company update  am march    marketwired dynavax presents promising clinical data from lead immunooncology candidate sd at the international congress on targeted anticancer therapies  am march    marketwired biotechs outlook strengthens after president trumps speech todays reports on dynavax technologies and lexicon pharmaceuticals  am march    accesswire dynavax to present at the cowen and company th annual health care conference  am march    marketwired dynavax announces fda acceptance for review of its complete response to november  crl and pdufa action date for heplisavbtm  pm feb    marketwired dynavax to present at the  rbc capital markets global healthcare conference  am feb    marketwired shareholder alert lundin law pc announces securities class action lawsuit against dynavax technologies corporation and encourages investors with losses to contact the firm  pm jan    accesswire upcoming deadline levi  korsinsky llp reminds shareholders of dynavax technologies corporation of a class action lawsuit and a lead plaintiff deadline of january   – dvax  am jan    businesswire  bzx loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice    dvaxnasdaq cm stock quote  dynavax technologies corp  bloomberg markets error could not add to watchlist x  watchlist dynavax technologies corp dvaxus nasdaq cm usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases  fda rejects dynavaxs hep b vaccine again dvax  investopedia  dow scores slim new record while nasdaq sp  fall  the street  stocks waver as wall streets trump rally fades  the street  stocks waver as wall streets trump rally fades  the street  stocks fluctuate as trump rally fades tech selloff resumes  the street there are currently no news stories for this ticker please check back later  lifshitz  miller llp files amended shareholder derivative lawsuit on behalf of dynavax technologies corporation  loncar cancer immunotherapy index conducts semiannual rebalance  dynavax presents updated data for sd in combination with keytrudar pembrolizumab highlighting an orr in  out of   liver fibrosis therapeutic development and pipeline review h  research report now available at rnrmarketresearch  dynavax to present data on sd in combination with keytrudar at the  american society of clinical oncology asco ann  dynavax reports first quarter  financial results  dynavax announces fda advisory committee meeting to review heplisavb  dynavax announces upcoming data presentations for three tlr agonist programs at the  american association for cancer rese  dynavax reports fourth quarter and year end  financial results and company update  dynavax presents promising clinical data from lead immunooncology candidate sd at the international congress on targete there are currently no press releases for this ticker please check back later profile dynavax technologies corporation discovers develops and is seeking to commercialize products based on immunostimulatory sequences the company is developing products to treat and prevent allergies infectious diseases and chronic inflammatory diseases using approaches that alter immune system responses in specific ways address  seventh streetsuite berkeley ca united states phone  website wwwdynavaxcom executives board members eddie gray chief executive officer michael s ostrach senior vpcfochief bus ofcrir robert lee coffman senior vpchief scientific ofcr david f novack senior vpoperations  quality steven n gersten vpsecygeneral counsel show more dynavax announces fda advisory committee meeting to review heplisavb nasdaqdvax facebook google linkedin twitter email rss aug   previous release  next release pdf add to briefcase file is in briefcase dynavax announces fda advisory committee meeting to review heplisavb advisory committee meeting scheduled for november   berkeley ca  marketwired    dynavax technologies corporation nasdaq dvax announced today that the vaccines and related biological products advisory committee vbrpac will review the biologics license application bla for heplisavb™ hepatitis b vaccine recombinant adjuvanted at its meeting on november   the fda has indicated it will communicate questions for the vrbpac to address closer in time to the meeting date heplisavb the companys vaccine candidate for immunization against infection caused by all known subtypes of hepatitis b virus in adults ages  years of age and older is currently under fda review with a december   prescription drug user fee act pdufa action date the upcoming vbrpac meeting is the next step towards our goal of obtaining regulatory approval for heplisavb and we are prepared for it said eddie gray chief executive officer of dynavax the company looks forward to discussing heplisavb with the advisory committee and continuing to work closely with the fda through the review process the vrbpac reviews and evaluates data regarding the safety efficacy and appropriate use of vaccines and related biological products that are intended for use in the prevention treatment or diagnosis of human diseases about hepatitis b hepatitis b is a viral disease of the liver that can become chronic and can lead to cirrhosis of the liver hepatocellular carcinoma and death in the us the cdc estimates that approximately  hepatitis b infections continue to occur annually with the vast majority occurring in adults there is no cure for hepatitis b and disease prevention through effective vaccination is critical to reducing the spread of the disease currently marketed hepatitis b vaccines are administered in three doses over a sixmonth schedule results of a published vaccine safety datalink study showed that  percent of adults completed the currently available threedose hepatitis b vaccine series in one year those who do not complete the series may not be adequately protected against hepatitis b about heplisavb heplisavb is an investigational adult hepatitis b vaccine that combines hepatitis b surface antigen with a proprietary tolllike receptor  agonist to enhance the immune response heplisavb is administered in two doses over one month in phase  trials heplisavb demonstrated higher and earlier protection with fewer doses than a currently licensed hepatitis b vaccine it also demonstrated a similar safety profile to the existing vaccine the investigational vaccines safety profile is based on clinical trials that generated safety data from more than  participants the most frequently reported local reaction was injection site pain the most common systemic reactions were fatigue headache and malaise all of which were similar to an existing vaccine dynavax has worldwide commercial rights to heplisavb about dynavax dynavax a clinicalstage biopharmaceutical company discovers and develops novel vaccines and therapeutics in the areas of infectious diseases and oncology dynavaxs lead product candidates are heplisavb a phase  investigational adult hepatitis b vaccine and sd an investigational cancer immunotherapeutic currently in several phase  studies for more information visit wwwdynavaxcom forwardlooking statements this press release contains forwardlooking statements including statements regarding heplisavb and fda review these statements are subject to a number of risks and uncertainties that could cause actual results to differ materially including whether there will be changes in the data or interpretation whether the final study results will be deemed satisfactory by the fda whether additional studies or manufacturing process enhancements will be required or other issues will arise that will delay the bla review or negatively impact the review and approval by the fda initiation enrollment and completion of preclinical studies and clinical trials of our other product candidates including sd the results of clinical trials and the impact of those results on the initiation or continuation of subsequent trials and issues arising in the regulatory process and other risks detailed in the risk factors section of our most recent current periodic report filed with the sec these statements represent our estimates and assumptions only as of the date of this press release we do not undertake any obligation to update publicly any such forwardlooking statements even if new information becomes available information on dynavaxs website at wwwdynavaxcom is not incorporated by reference in our current periodic reports with the sec contactkatie hogan wcg  email contactcontactmichael ostrachchief financial officerdynavaxemail contact source dynavax technologies news provided by acquire media dynavax  home search homeabout usour visionmanagement teamboard of directorsdynavax europecontactour sciencetolllike receptorstlr agoniststlr inhibitorspublicationsour pipelineadjuvantshbsagcancer immunotherapysddvpreclinicalimmunemediated diseasesazd asthmainvestors and mediaoverviewpress releasesevents  presentationsstock informationanalyst coveragefinancialssec filingsannuals and proxiescorporate governanceboard of directorscommittee compositioncontact the boardcontact uscareersus job opportunitieseu job opportunitiesbenefits contact us search homeabout us›our vision›management team›board of directors›dynavax europeour science›tolllike receptors›publicationsour pipeline›adjuvants›cancer immunotherapy›immunemediated diseasesinvestors and media›overview›press releases›events  presentations›stock information›analyst coverage›financials›sec filings›annuals and proxies›corporate governance›contact uscareers›us job opportunities›eu job opportunities›benefits experts in tlr biology we are developing immunotherapies based on cuttingedge tolllike receptor tlr biology and its ability to modulate the immune system learn more   cancer immunotherapy through our expertise in tlr biology we are developing compounds designed to stimulate multiple innate mechanisms of tumor killing and development of immune memory associated with tumorspecific antigens learn more   ‹ › cancer immunotherapy utilizing tolllike receptor biology to leverage the power of the bodys immune response to stimulate multiple innate mechanisms activating a cascade of antitumor activities learn more ›    hepatitis b vaccine hbsag is an investigational adult hepatitis b vaccine that combines hepatitis b surface antigen with  our proprietary tlr agonist learn more › news jun dynavax presents updated data for sd in combination with keytrudar pembrolizumab highlighting an orr in  out of  patients naive to an antipd or antipdl therapy may dynavax to present data on sd in combination with keytrudar at the  american society of clinical oncology asco annual meeting may dynavax reports first quarter  financial results view all news our values at dynavax we are proud of the work we do our corporate values provide the foundation of our culture and how we operate as a company learn more › contact us    terms  conditions  dynavax technologies corporation all rights reserved dynavax technologies  west berkeley   visitors foursquarelog insign upnearbyget inspiredtop pickstrendingfoodcoffeenightlifefunshoppingdynavax technologiestech startupwest berkeley berkeleysavesharetipsdynavax technologiesno tips and reviewslog in to leave a tip herepostno tips yetwrite a short note about what you liked what to order or other helpful advice for visitors photorelated searchesdynavax technologies berkeley  dynavax technologies berkeley photos  dynavax technologies berkeley location  dynavax technologies berkeley address  dynavax technologies berkeley  dynavax technologies berkeley  dynavax technologies west berkeley berkeleyaboutblogbusinessescitiesdevelopershelpjobscookies updatedprivacy updatedtermsenglishenglish français deutsch bahasa indonesia italiano 語 한국어 português русский español ภาษาไทย türkçe citiesatlantaaustinbostonchicagodallasdenverhoustonlas vegaslos angelesnew yorkphiladelphiaportlandsan diegosan franciscoseattlewashington dccountriesbelgiumbrazilcanadachilefinlandfrancegermanygreat britainhungaryindonesiajapanmexiconetherlandsphilippinesrussiasingaporespainthailandturkeymore great places in berkeleyabcdefghijklmnopqrstuvwxyzfoursquare    lovingly made in nyc  sfdynavax technologies ninth stberkeley ca united statesget directions see moreunited states » alameda county » berkeley » professional  other places » office » tech startupis this your business claim it nowmake sure your information is up to date plus use our free tools to find new customersyou must enable javascript to use foursquarecomwe use the latest and greatest technology available to provide the best possible web experienceplease enable javascript in your browser settings to continuedownload foursquare for your smart phone and start exploring the world around you yelp yelp sorry you’re not allowed to access this page contact yelp if you keep experiencing issues bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one